gms | German Medical Science

84. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

08.05. - 12.05.2013, Nürnberg

VSB in mixed hearing loss with oto- and tympanosclerosis

Meeting Abstract

Suche in Medline nach

  • corresponding author Burkard Schwab - HNO-Klinik; MHH, Hannover
  • Hannes Maier - HNO-Klinik, MHH, Hannover
  • Rolf-Bendikt Salcher - HNO-Klinik, MHH, Hannover

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 84. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Nürnberg, 08.-12.05.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. Doc13hnod530

doi: 10.3205/13hnod530, urn:nbn:de:0183-13hnod5305

Veröffentlicht: 15. April 2013

© 2013 Schwab et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: The Vibrant Soundbridge (VSB) is a middle ear hearing implant originally intended for use in persons with mild to severe sensorineural hearing loss. In 2007 the indications for the device have been extended to include persons with conductive and mixed hearing losses. Special couplers were introduced for optimal energy transfer to the cochlea. New techniques were introduced for direct inner ear stimulation (Power-Stapes, vibrant DACS).

Methods: The present study investigated a group of subjects with conductive and mixed hearing losses (tympanosclrosis, otosclerosis) who received a VSB as a “power-stapes” or as a “Vibrant-DACS). Patients were evaluated pre-operatively and at regular intervals. The final observation interval was conducted after 6 months of VSB use.

Results: On average, aided word understanding improved with both applications by about 60% over the unaided condition with an average functional gain of approximately 20 to 40 dB across the frequency range 500 to 8,000 Hz. Speech gain averaged about 40 dB. Direct acoustical cochlear stimulation resulted in an average functional hearing gain of 36.1 dB (range, 24.2–47.5 dB). Although the greatest amplification was observed in the higher frequencies, there also was a significant improvement in the lower frequencies. The surgery was not related to any difficulties; vertigo, inner ear trauma, or further complications did not occur.

Conclusions: Taken together, the results support that the VSB may be safely and effectively also used in conductive and mixed hearing losses (esp. in otosclerosis cases with different coupling methods and different surgical (and more or less high sophisticated) techniques.

Der Erstautor gibt keinen Interessenkonflikt an.